Coexistence of a novel RGS18 downstream intergenic region ALK fusion and a THUMPD2-ALK fusion in a lung adenocarcinoma patient and response to crizotinib

Wang Yan-li; Wu Zhen-zhen; Zhang Heng-rui; Chen Dong-sheng; Zhao Xin

首页> 外文期刊>Lung cancer: Journal of the International Association for the Study of Lung Cancer >Coexistence of a novel RGS18 downstream intergenic region ALK fusion and a THUMPD2-ALK fusion in a lung adenocarcinoma patient and response to crizotinib

【24h】

Coexistence of a novel RGS18 downstream intergenic region ALK fusion and a THUMPD2-ALK fusion in a lung adenocarcinoma patient and response to crizotinib

机译：新型RGS18下游亚核区域ALK融合的共存和肺腺癌患者中的乳头2-ALK融合，并对CRIZOTINIB进行反应

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Lung cancer: Journal of the International Association for the Study of Lung Cancer》 |2021年第1期|共3页
作者
Wang Yan-li; Wu Zhen-zhen; Zhang Heng-rui; Chen Dong-sheng; Zhao Xin;
展开▼
作者单位

Jiangsu Prov Hosp Dept Resp &

Crit Care Med Nanjing 210002 Peoples R China;

Jiangsu Prov Hosp Dept Resp &

Crit Care Med Nanjing 210002 Peoples R China;

Jiangsu Prov Hosp Dept Resp &

Crit Care Med Nanjing 210002 Peoples R China;

Jiangsu Simcere Diagnost Co Ltd State Key Lab Translat Med &

Innovat Drug Dev Nanjing 210002;

Jiangsu Prov Hosp Dept Resp &

Crit Care Med Nanjing 210002 Peoples R China;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Rapid response of brain metastasis to crizotinib in a patient with KLC1-ALK fusion and MET gene amplification positive non-small cell lung cancer：a case report [J] . Peng Wang, Pei Xiao, Yingnan Ye, 癌症生物学与医学：英文版 . 2017,第002期
2. Rapid response of brain metastasis to crizotinib in a patient with KLC1-ALK fusion and MET gene amplification positive non-small cell lung cancer: a case report [J] . Peng Wang, Pei Xiao, Yingnan Ye, 癌症生物学与医学（英文版） . 2017,第002期
3. Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion [J] . Cun-Liang Cai, Ming-Qiang Zhang, Jun Guo, 中华医学杂志（英文版） . 2019,第024期
4. ALK gene expression status in pleural effusion predicts tumor responsiveness to crizotinib in Chinese patients with lung adenocarcinoma [J] . Zheng Wang, Xiaonan Wu, Xiaohong Han, 中国癌症研究（英文版） . 2016,第006期
5. Coexistence of a Novel PRKCB-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient and Response to Crizotinib [J] . Luo Jing, Gu Dejian, Lu Huasong, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2019,第12期

机译：新型PRKCB-ALK，EML4-ALK双融合在肺腺癌患者中的共存，并对CRIZOTINIB的反应
6. A Novel Intergenic Region between CENPA and DPYSL5-ALK Exon 20 Fusion Variant Responding to Crizotinib Treatment in a Patient with Lung Adenocarcinoma [J] . Fei Xiaodong, Zhu Liqun, Zhou Hongxuan, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2019,第9期

机译：CENPA和DPYSL5-ALK外显子20融合变体在肺腺癌患者中对屈服的融合变异的新型血栓变体
7. Rare coexistence of three novel CDCA7-ALK, FSIP2-ALK, ALK-ERLEC1 fusions in a lung adenocarcinoma patient who responded to Crizotinib [J] . Zhao Guojiang, Chen Lin, Xiao Mingzhe, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2021,第1期

机译：在肺腺癌患者中罕见的三种新型CDCA7-ALK，FSIP2-ALK，ALK-EREC1融合的罕见共存
8. Radiomics Biomarkers from PET/CT Multi-modality Fusion Images for the Prediction of Immunotherapy Response in Advanced Non-small Cell Lung Cancer Patients [C] . Wei Mu, Jin Qi, Hong Lu, SPIE Medical Imaging Conference . 2018

机译：PET / CT多模态融合图像的放射性标记生物标志物用于预测晚期非小细胞肺癌患者的免疫治疗反应
9. Localization-based Signaling Pathway Dependence of ROS1 Fusions and a Novel Role for Ras in EML4-ALK-Driven Lung Cancer [D] . Neel, Dana Sarabeth. 2017

机译：ROS1融合的基于本地化的信号通路依赖性和在EML4-ALK驱动的肺癌中Ras的新作用。
10. Coexistence of a novel CCNY-ALK and ATIC-ALK double-fusion in one patient with ALK-positive NSCLC and response to crizotinib: a case report [O] . Xuan Wu, Hanqiong Zhou, Zhen He, 2020

机译：用ALK阳性NSCLC的一名患者共存新的CCNY-ALK和ATIC-ALK双重融合并对CRIZOTINIB的反应：案例报告
11. Coexistence of a Novel PRKCB-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient and Response to Crizotinib [O] . Jing Luo, Dejian Gu, Huasong Lu, 2019

机译：新型PRKCB-ALK，EML4-ALK双融合在肺腺癌患者中的共存，并对CRIZOTINIB的反应

Coexistence of a novel RGS18 downstream intergenic region ALK fusion and a THUMPD2-ALK fusion in a lung adenocarcinoma patient and response to crizotinib

著录项

相似文献

相关主题

期刊订阅